Quantification of regional glial fibrillary acidic protein levels in Alzheimer's disease

Acta Neurologica Scandinavica

Volumn 107, Issue 5, 2003, Pages 318-323

  Ross, G Webster ^a,c,e,g   O'Callaghan, J P ^b   Sharp, D S ^b   Petrovitch, H ^a,c,e,g   Miller, D B ^b   Abbott, R D ^c,d,e,g   Nelson, J ^e   Launer, L J ^f   Foley, D J ^f   Burchfiel, C M ^b   Hardman, J ^c,g   White, L R ^a,c,e,g  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^f NATIONAL INSTITUTE ON AGING   (United States)

^g KUAKINI MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; Dementia; Glial fibrillary acidic protein; Gliosis

Indexed keywords

BRAIN PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIOSIS; HUMAN; HUMAN TISSUE; MALE; OCCIPITAL LOBE; PARIETAL LOBE; PROTEIN DETERMINATION; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASTROCYTES; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FRONTAL LOBE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; OCCIPITAL LOBE; PARIETAL LOBE; TEMPORAL LOBE;

EID: 0038692293     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2003.02098.x     Document Type: Article

References (30)

1. O'CALLAGHAN JP, MILLER DB, REINHARD JF JR. Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Brain Research 1990;521:73-80.
2. O'CALLAGHAN JP. Quantitative features of reactive gliosis following toxicant-induced damage of the CNS. Ann N Y Acad Sci 1993;679:195-210.
3. PIKE CJ, CUMMINGS BJ, COTMAN CW. Early association of reactive astrocytes with seniles plaques in Alzheimer's disease. Exp Neurol 1995;132:172-9.
4. LE PRINCE G, DELAERE P, FAGES C, DUYCKAERTS C, HAUW J-J, TARDY M. Alterations of glial fibrillary acidic protein mRNA level in the aging brain and in senile dementia of the Alzheimer type. Neuroscience Lett 1993;151:71-3.
5. Goss JR, FINCH CE, MORGAN DG. Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain. Neurobiol Aging 1991;12:165-70.
6. BRAAK H, BRAAK E. Neuropathological staging of Alzheimer related changes. Acta Neuropathol 1991;82:239-59.
7. Kagan A. In: The honolulu heart program: an epidemiological study of coronary heart disease and stroke (KAGAN A. eds.). Amsterdam: Hardwood Academic Publishers, 1996.
8. SYME SL, MARMOT MU, KATO H, RHOADS G. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: introduction. Am J Epidemiol 1975;102:477-80.
9. WHITE L, PETROVITCH H, ROSS GW et al. Prevalence of dementia in older Japanese-American men in Hawaii: the Honolulu-Asia Aging Study. JAMA 1996;276:955-60.
10. TENG EL, HASEGAWA K, HOMMA A et al. A practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 1994;6:45-58.
11. WHITE L, MASAKI K, ROSS GW, PETROVITCH H, CHIU D, TENG E. Estimation of the sensitivity and specificity of a dementia screening test in a population-based survey. Neurobiol Aging 1994;15(Suppl. 1):171.
12. MORRIS JC, HEYMAN A, MOHS RC et al. The Consortium to establish a registry for Alzheimer's disease (CERAD), part 1: clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-65.
13. WELSH K, BUTTERS N, HUGHES J, MOHS R, HEYMAN A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 1991;48:278-81.
14. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and statistical manual of mental disorders, Revised 3rd edn. Washington, DC: American Psychiatric Association, 1987.
15. BERG L. Mild senile dementia of the Alzheimer's type: diagnostic criteria and natural history. Mt Sinai J Med 1988;55:87-96.
16. MCKHANN G, DRACHMAN D, FOLSTEIN M, KATZMAN R, PRICE D, STADLAN EM. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984;34:939-44.
17. PETROVITCH H, NELSON J, SNOWDON D et al. Microscope field size and the neuropathologic criteria for Alzheimer's disease. Neurology 1997;49:1175-6.
18. O'CALLAGHAN JP. Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol. Teratol. 1991;13:275-81.
19. BROCK TO, O'CALLAGHAN JP. Quantitative changes in the synaptic vesicle proteins synapsin I and p38 and the astrocyte-specific protein glial fibrillary acidic protein are associated with chemical-induced injury to the rat central nervous system. J Neurosci 1987;7:931-42.
20. O'CALLAGHAN JP, IMAI H, MILLER DB, MINTER A. Quantitative immunoblots of proteins resolved from brain homogenates: underestimation of specific protein concentration and of treatment effects. Anal Biochem 1999;274:18-26.
21. ROSNER B. Fundamentals of biostatistics. Pacific Grove, CA: Duxbury, 2000.
22. BEACH TG, WALKER R, MCGEER EG. Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 1989;2:420-36.
23. VIJAYAN VK, GEDDES JW, ANDERSON KJ, CHANG-CHUI H, ELLIS WG, COTMAN CW. Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation. Exp Neurol 1991;112:72-8.
24. KUMAR A, SCHAPIRO MB, GRADY C et al. Studies in Alzheimer's disease. Neuropsychopharmacology 1991;4:35-46.
25. BENSON DF. PET/dementia: an update. Neurobiol Aging 1988;9:87-8.
26. MEGURO K, BLAIZOT X, KONDOH Y, LE MESTRIC C, BARON JC, CHAVOIX C. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease. Brain 1999;122:1519-31.
27. NICHOLS NR, DAY JR, LAPING NJ, JOHNSON SA, FINCH CE. GFAP mRNA increases with age in rat and human brain. Neurobiol Aging 1993;14:421-9.
28. ROSENGREN LE, WIKKELSO C, HAGBERG L. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults. J Neuroscience Meth 1994;51:197-204.
29. KREUTZBERG GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-8.
30. ENG LF, LEE YL. Intermediate filaments in astrocytes. In: Keffermann H, Ransom BR, eds. Neuroglia. Oxford: Oxford University Press, 1995: 650-67.